Pfizer Asks for COVID-19 Booster Shot Approval, FDA Rejects Plan

2021-09-15 3 Dailymotion

Pfizer said that vaccine protection may wane approximately after six months following the second dose. However, the FDA rejected the plan on Friday, Sept. 17.

Related Videos

US FDA OKs booster shot of Pfizer vaccine; Pfizer says kids 5-11 can be vaccinated; Biden approves 500-M more COVID-19 vaccine doses for developing countries; Tokyo unveils library dedicated for author Haruki Murakami | via Meg Luna

Pfizer Seeks FDA Approval For Booster Dose Move To Improve Tax Efficacy NewsX

COVID-19 vaccine ng Pfizer, may full approval na mula sa U.S. FDA | UB

Pfizer-Biontech COVID vaccine, binigyan ng full approval ng US FDA | SONA

Pfizer Seeks Full FDA Approval For Covid Antiviral Pill Paxlovid - 1breakingnews.com

Breaking News: COVID vaccine ng Pfizer-BioNTech, may full approval na sa US FDA | Saksi

Facebook Displays FDA Approval Of Pfizer Covid-19 Vaccine

Pfizer Covid-19 Vaccine Receives Full Approval From US FDA

Bakuna ng Pfizer-BioNTech, kauna-unahang COVID-19 vaccine na binigyan ng full approval ng US FDA | 24 Oras

GLOBALITA | Higit 150 patay sa matinding pagbaha sa Western Europe; Review para sa full approval ng COVID-19 vaccine ng Pfizer at Biontech, inuna ng US FDA; Mga estudyanteng anak ng 'di fully vaccinated na magulang sa ilang lugar sa China, posibleng 'di